Chemical and Pharmaceutical Bulletin · 1999 · 69 citations · 0 references
Life SciencesMedicinal ChemistryPharmacologyBiochemical PharmacologyDrug DiscoveryHypersensitivityAntioxidant DefenseCytochrome P450 EnzymesEnzyme InhibitionHistamine Release5-Lipoxygenase InhibitionAntigen-antibody InteractionsAntigen-antibody RecognitionBenzimidazole SynthesisDrug-induced Histamine ReleaseHistamine Release InhibitionHistamine Release SuppressionRat Liver Microsomes
Syntheses were conducted of novel benzimidazole derivatives that suppress histamine release from mast cells, inhibit 5-lipoxygenase, and possess antioxidative action. Among the compounds synthesized, 1-[2-[2-(4-hydroxy- 2,3,5-trimethylphenoxy)ethoxy]ethyl]-2-(4-methyl-1- homopiperazino)benzimidazole (22) potently suppressed histamine release from rat peritoneal mast cells triggered by the antigen-antibody reaction, inhibited 5-lipoxygenase in rat basophilic leukemia-1 (RBL-1) cells, and prevented the NADPH-dependent lipid peroxidation induced by Fe(3+)-ADP in rat liver microsomes, in addition to an antagonizing the contraction of guinea pig ileum caused by histamine.